JPRN-UMIN000037138
Recruiting
N/A
A pilot study; The relationship between blood test during cardiopulmonary bypass and coagulation function evaluated by thromboelastometry after taking off cardiopulmonary bypass. - A pilot study; The relationship between blood test during cardiopulmonary bypass and coagulation function evaluated by thromboelastometry after taking off cardiopulmonary bypass.
agoya University Hospital0 sites50 target enrollmentJuly 5, 2019
ConditionsPatients who receive cardiac surgery
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Patients who receive cardiac surgery
- Sponsor
- agoya University Hospital
- Enrollment
- 50
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not Yet Recruiting
N/A
Correlation of the blood test results between fingertip blood samples collected with multifunctional microliter-scale blood collection tube and conventional venous or arterial bloodThis study can make blood samplig to be minimally invasive.JPRN-jRCT1032220431Aoyagi Jun20
Completed
N/A
A study examining the relationship between blood flow waveform indices and lifestyle-related disease indicesHealthy adultsJPRN-UMIN000045013Kao Corporation200
Completed
N/A
A clinical study on the correlation between blood glucose level and glucose concentration in aqueous humor of cataract surgery patientsCataractJPRN-UMIN000017362Department of Ophthalmology, Keio University School of Medicine10
Active, Not Recruiting
N/A
Evaluation of the pharmacodynamic effect of the combination of Sildenafil and Riociguat on blood pressure and other safety parametersPulmonary arterial hypertensionMedDRA version: 14.1Level: PTClassification code 10064911Term: Pulmonary arterial hypertensionSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2010-018863-40-DEBayer HealthCare AG18
Active, Not Recruiting
N/A
An interaction study to evaluate changes in blood pressure following 1, 1.5, 2, and 2.5 mg riociguat tid (dose titration) compared to placebo treatment on the background of stable sildenafil pretreatment in subjects with symptomatic pulmonary arterial hypertension - PATENT PLUSPulmonary arterial hypertension.MedDRA version: 9.1Level: LLTClassification code 10064911EUCTR2010-018863-40-ITBayer Health Care AG36